GPT and metabolic dysfunction-associated steatohepatitis: We evaluated ALT-801 in a translational, biopsy-confirmed diet-induced obese (DIO) mouse model of NASH (DIO-NASH)22 and investigated the effects of a 12 week treatment regimen on metabolic and biochemical parameters, hepatic pathology, and individual changes in NAFLD Activity Score (NAS) and fibrosis stage.